CitiusTech, a health care technology company based in Princeton, appointed Bhaskar Sambasivan as president, the company announced June 7.
As the first U.S.-based senior executive for the company, Sambasivan will focus on strengthening CitiusTech’s client relationships, developing strategic offerings and driving business growth.
According to an announcement, CitiusTech has grown more than 20% annually for the past 17 years with projected revenue of over $250 million this year. The company’s digital technology offerings include health care product engineering, data management, advanced analytics, artificial intelligence, machine learning and automation.
“Bhaskar is a growth-focused leader with proven success in scaling health care technology businesses. His vast experience and his focus on operational excellence will be critical for us, as we embark on our next phase of growth,” said CitiusTech Chairman Dr. William Winkenwerder in a prepared statement. “We welcome him to the CitiusTech family and look forward to this journey with him.”
Sambasivan joins CitiusTech with more than three decades of experience in health care, life sciences and digital technology services. Most recently, he was president of patient services and chief strategy officer of Eversana, a life sciences platform company with offices in Berkeley Heights.
Prior to Eversana, Sambasivan was with Cognizant as global head of life sciences for more than a decade. Under his leadership, Cognizant’s life sciences business grew over thirty-fold in 15 years, according to the announcement.
“As the health care industry becomes more patient and consumer centric, all healt hcare segments will transform their business and operating models to adapt to the new normal. As a Born Digital company, CitiusTech is uniquely positioned to drive this technology-enabled health care business transformation. I cannot be more excited to be part of this great company that is exclusively focused on health care, to help lead the next phase of growth and make a significant difference to our health care clients and patients we serve,” said Sambasivan.
